|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 2 of 58 found articles
| Title: |
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial |
| Author: |
Park, Keunchil Tan, Eng-Huat O'Byrne, Ken Zhang, Li Boyer, Michael Mok, Tony Hirsh, Vera Yang, James Chih-Hsin Lee, Ki Hyeong Lu, Shun Shi, Yuankai Kim, Sang-We Laskin, Janessa Kim, Dong-Wan Arvis, Catherine Dubos Kölbeck, Karl Laurie, Scott A Tsai, Chun-Ming Shahidi, Mehdi Kim, Miyoung Massey, Dan Zazulina, Victoria Paz-Ares, Luis |
| Appeared in: |
Lancet oncology |
| Paging: | Volume 17 (2016) nr. 5 pages 13 p. |
| Year: |
2016 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 2 of 58 found articles
| << previous | next >> |